Simplex Trading’s Lisata Therapeutics LSTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,259
Closed -$10.4K 10593
2022
Q1
$13K Buy
+1,259
New +$14.4K ﹤0.01% 8666
2021
Q1
Sell
-1,021
Closed -$30.9K 9475
2020
Q4
$21K Buy
1,021
+453
+80% +$10.8K ﹤0.01% 6941
2020
Q3
$15K Buy
+568
New +$18K ﹤0.01% 6557
2020
Q2
Sell
-60
Closed -$1.76K 8019
2020
Q1
$1K Buy
60
+55
+1,100% +$2.13K ﹤0.01% 7374
2019
Q4
$0 Buy
+5
New +$180 ﹤0.01% 7659
2019
Q3
Sell
-1
Closed 7604
2019
Q2
$0 Buy
+1
New +$44 ﹤0.01% 7488
2016
Q1
Sell
-33
Closed -$5K 5943
2015
Q4
$5K Hold
33
﹤0.01% 3877
2015
Q3
$7K Buy
33
+10
+43% +$2.51K ﹤0.01% 3737
2015
Q2
$6K Buy
+23
New +$8.55K ﹤0.01% 3523
2015
Q1
Sell
-7
Closed -$3.79K 5293
2014
Q4
$4K Buy
+7
New +$4.76K ﹤0.01% 3263

Other funds holding LSTA

Simplex Trading's LSTA Position: Q2 2022 in Review

Simplex Trading sold out of Lisata Therapeutics (LSTA) in Q2 2022, closing a stake of 1,259 shares — an estimated $10.4K sold.

Simplex Trading first reported a position in LSTA in Q4 2014 and held it in 10 quarters. The position peaked at $21K in Q4 2020. 34 funds tracked by Wall St. Rank hold LSTA as of Q2 2022.

  • Simplex Trading reported no remaining Lisata Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Simplex Trading sold 1,259 Lisata Therapeutics shares in Q2 2022, an estimated $10.4K.
  • Simplex Trading first reported a position in Lisata Therapeutics in Q4 2014 and held it in 10 quarters.
  • Simplex Trading's Lisata Therapeutics position peaked at $21K in Q4 2020.
  • 34 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q2 2022.

Based on Simplex Trading's 13F filing for Q2 2022, filed 3 Aug 2022.